A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...

Monash University has cut law tutorials, reducing some students’ contact with teaching staff by up to six hours a semester in what has been described as a “cost-cutting, degree-factory move”. The ...

Proof-of-concept exploit code has been published for a critical remote code execution flaw in protobuf.js, a widely used JavaScript implementation of Google's Protocol Buffers. The tool is highly ...

Leaked API keys are nothing new, but the scale of the problem in front-end code has been largely a mystery - until now. Intruder’s research team built a new secrets detection method and scanned 5 ...

Samsung Electronics is accelerating construction of its P5 semiconductor line in Pyeongtaek, South Korea, as it moves toward a 2028 production target. The project is a central component of the company ...

Thirty years ago today, Netscape Communications and Sun Microsystems issued a joint press release announcing JavaScript, an object scripting language designed for creating interactive web applications ...

Social Links and Confidants return in Persona 5: The Phantom X, but they go by a new name: Synergy Bonds. Synergy Bonds are The Phantom X’s take on social stats tied to NPCs that you can unlock once ...

The daily reset time in Persona 5: The Phantom X is when your dailies refresh, allowing you to complete daily goals and collect rewards. If you’re playing on the global server, the daily reset time ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Last year, I reviewed the Cevaton S6 and I thought it was a nice and convenient laptop screen extender. Now, I have the Cevaton P5 in house and this one may be a better choice for many users. While ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.